A detailed history of Sterneck Capital Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Sterneck Capital Management, LLC holds 53,691 shares of OGN stock, worth $404,293. This represents 0.27% of its overall portfolio holdings.

Number of Shares
53,691
Previous 47,092 14.01%
Holding current value
$404,293
Previous $455,000 25.93%
% of portfolio
0.27%
Previous 0.24%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$8.4 - $10.85 $55,431 - $71,599
6,599 Added 14.01%
53,691 $573,000
Q2 2025

Jul 16, 2025

BUY
$8.04 - $14.72 $378,619 - $693,194
47,092 New
47,092 $455,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Sterneck Capital Management, LLC Portfolio

Follow Sterneck Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterneck Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterneck Capital Management, LLC with notifications on news.